We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Dramatic Genetic Consequences of Single Amino Acid Change

By Biotechdaily staff writers
Posted on 18 Sep 2002
Researchers have found that a mutation in mice resulting in the replacement of a single amino acid in the Rad50 protein was sufficient to cause birth defects and increased incidence of cancer due to accumulated errors in DNA metabolism. More...
The finding was reported in the September 1, 2002, issue of Genes & Development.

Rad 50 is one of several proteins involved in various aspects of DNA metabolism, including the cellular response to DNA damage, DNA recombination, and the maintenance of chromosome ends (telomeres). As mutants completely lacking Rad50 do not survive, investigators from the University of Wisconsin Medical School (Madison, USA; www.wisc.edu) developed a mouse model with a point mutation in the Rad50 gene that resulted in a single amino change in the protein.

The Rad50-mutant mice displayed partial embryonic lethality, with the viable mice being only about half normal size and having severe testis and bone marrow cell attrition, which caused a large number of the mice to die by three months of age due to the severe anemia that resulted from progressive bone marrow depletion. Longer-lived Rad50-mutant mice exhibited a predisposition to lymphoma development due to a general inability to maintain the integrity of their genome.

This study demonstrated that a single amino acid change in Rad50 had far-reaching effects on the accurate transmission of genetic information from one cell generation to the next, resulting in an impaired ability to maintain stem cell populations and a predisposition to cancer. Extrapolating from mice to humans, it may be that even subtle genetic changes, such as a single amino acid substitution, may underlie cancer susceptibility in the human population.



Related Links:
Univ. of Wisconsin

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.